Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Novagenic Affinity logo — Empresa pionera en México para el conocimiento y tecnología...

Novagenic Affinity

Empresa pionera en México para el conocimiento y tecnología genómica en el desarrollo de tratamientos personalizados.

Founded 2018 Mexico Mexico 12 employees Seed Total: $200.00K Biotechnology, Health Care +1

General Information

Company Name Novagenic Affinity
Founded Year 2018
Location Mexico Mexico
Founders / Decision Makers
Team member
Employees 12
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Seed
Business Model B2C, D2C, B2B2C
Revenue Model Product Sales, Service Fee, One Time Purchase
Social

BounceWatch is an independent company data service, not affiliated with Novagenic Affinity. To contact Novagenic Affinity, visit novagenic.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Novagenic Affinity compare?

A PDF of Novagenic Affinity and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Novagenic Affinity soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Novagenic Affinity

Novagenic Affinity, founded in 2018 and headquartered in Mexico, is emerging as a prominent player in the fields of Biotechnology, Health Care, and Pharmaceutical industries. Known for being a forerunner in applying genomic knowledge and technology for personalized medicine, it operates under the compelling motto: "Empresa pionera en México para el conocimiento y tecnología genómica en el desarrollo de tratamientos personalizados."

The company emphasizes improving individual health through personalized medical treatments. Though still in its seed stage, Novagenic Affinity has demonstrated strong foundational development, evidenced by a $200.00K Seed Round investment as of 31 August 2017, with participation from investor Envelp. This positions the company uniquely for continued growth and innovation in genomic-based health solutions.

Business keywords: genomic technology, personalized medicine, pharmacogenetics, metabolic phenotype analysis, precision medicine, treatment personalization, medical diagnostics, health technology

Services & Products

Pharmacogenomic testing
Genetic analysis for drug prescription
Affinity genetic tests

Target Customers

Healthcare providers Doctors Patients seeking personalized medication plans Neurology and psychiatry practitioners

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $200.00K 1
Envelp
31 Aug 2017

Novagenic Affinity Alternatives & Competitors

Novagenic Affinity vs
Mendelics
Mendelics Brazil

Análise genômica ao alcance de todos

154 employees
Biotechnology, Health Care
Novagenic Affinity vs
NalaGenetics
NalaGenetics Singapore

Unlock your health secrets through the power of DNA

Non Equity Assistance
73 employees
Biotechnology, Health Care
Novagenic Affinity vs
SeqOne
SeqOne France

From Genome to Personalized Medicine

Venture round
108 employees
Analytics, Big Data

FAQ About Novagenic Affinity

Empresa pionera en México para el conocimiento y tecnología genómica en el desarrollo de tratamientos personalizados.
Novagenic Affinity was founded in 2018.
Novagenic Affinity is headquartered in Mexico.
Novagenic Affinity operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on genomic technology, personalized medicine, pharmacogenetics and metabolic phenotype analysis. Its customers include Healthcare providers, Doctors and Patients seeking personalized medication plans.
Novagenic Affinity has a B2C, D2C and B2B2C business model. Its revenue comes from Product Sales, Service Fee and One Time Purchase.
Novagenic Affinity has approximately 12 employees.
Novagenic Affinity has completed 1 funding round, raising a total of $200.00K. The latest funding stage is Seed.
Novagenic Affinity offers: Pharmacogenomic testing, Genetic analysis for drug prescription, Affinity genetic tests.
Top alternatives and competitors to Novagenic Affinity include Mendelics, NalaGenetics, SeqOne, FullDNA, Diatech Pharmacogenetics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Novagenic Affinity and Mendelics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Novagenic Affinity, https://bouncewatch.com/company/novagenic, updated 28 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes